Koers Kamada Ltd. TEL AVIV STOCK EXCHANGE
Aandelen
KMDA
IL0010941198
Farmaceutische producten
Omzet 2024 * | 573 mln. 157 mln. 145 mln. | Omzet 2025 * | 706 mln. 193 mln. 179 mln. | Marktkapitalisatie | 1,2 mld. 326 mln. 303 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | 46 mln. 12,56 mln. 11,64 mln. | Nettowinst (verlies) 2025 * | 84 mln. 22,93 mln. 21,26 mln. | EV/omzet 2024 * | 2,09 x |
Nettoliquiditeiten 2024 * | - 0 0 | Nettoliquiditeiten 2025 * | - 0 0 | EV/omzet 2025 * | 1,69 x |
K/w-verhouding 2024 * |
-
| K/w-verhouding 2025 * |
-
| Werknemers | - |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 54,25% |
Recentste transcriptie over Kamada Ltd.
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Amir London
CEO | Chief Executive Officer | 55 | 09-12-13 |
David Tsur
FOU | Founder | 73 | 13-12-90 |
Chaime Orlev
DFI | Director of Finance/CFO | 53 | 31-12-17 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Ishay Davidi
BRD | Director/Board Member | 62 | 24-12-19 |
Leon Recanati
BRD | Director/Board Member | 76 | 01-05-05 |
David Tsur
FOU | Founder | 73 | 13-12-90 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+0,44% | 90,27 mld. | |
+9,61% | 44,05 mld. | |
-16,67% | 31,45 mld. | |
+44,99% | 23,35 mld. | |
-9,42% | 16,72 mld. | |
-25,92% | 15,09 mld. | |
-9,27% | 12,82 mld. | |
-7,57% | 11,95 mld. | |
+0,07% | 8,71 mld. |